Lentigen Corporation Receives U.S. Orphan Drug Designation for Novel Gene Therapy for Glioblastoma Multiforme
2/14/2013 8:33:25 AM
More...
|
Lentigen Corporation and UH Case Medical Center Initiate Phase I Trial Using Gene Therapy and Bone Marrow Stem Cells in the Treatment of Brain Cancer
11/14/2011 2:04:50 PM
More...
|
Lentigen Corporation Awarded $1.2 Million by U.S. Government Under the Qualifying Therapeutic Discovery Project
11/4/2010 6:52:33 AM
More...
|
Lentigen Corporation Awarded Phase II SBIR Grant for Clinical Development of TCR Immunotherapy Targeted to Melanoma
8/9/2010 9:28:15 AM
More...
|
Lentigen Corporation Awarded Phase I STTR Grant for Hunter Syndrome
5/18/2010 9:54:53 AM
More...
|
International AIDS Vaccine Initiative and Lentigen Corporation to Collaborate on Design of Novel AIDS Vaccine Candidate
4/22/2010 11:11:20 AM
More...
|
Lentigen Corporation Awarded Phase I SBIR Grant for Hepatitis C Vaccine
12/9/2009 10:02:33 AM
More...
|
Lentigen Corporation and Expression Therapeutics Sign Hemophilia Co-Development Agreement
2/4/2009 8:52:00 AM
More...
|
Lentigen Corporation, US Army Expand Partnership
10/2/2008 7:11:11 AM
More...
|
Lentigen Corporation Announces Relocation to New Facility
9/9/2008 9:33:04 AM
More...
|
|